These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36494319)

  • 21. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers.
    Yammine K; Kheir N; Assi C
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in Dermoepidermal Skin Substitutes for Diabetic Foot Ulcers.
    Álvaro-Afonso FJ; García-Álvarez Y; Lázaro-Martínez JL; Kakagia D; Papanas N
    Curr Vasc Pharmacol; 2020; 18(2):182-192. PubMed ID: 30963977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effective management of recalcitrant diabetic foot ulcers.
    Albert S
    Clin Podiatr Med Surg; 2002 Oct; 19(4):483-91. PubMed ID: 12471856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus.
    Liu Z; Dumville JC; Hinchliffe RJ; Cullum N; Game F; Stubbs N; Sweeting M; Peinemann F
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010318. PubMed ID: 30328611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study.
    Tallis A; Motley TA; Wunderlich RP; Dickerson JE; Waycaster C; Slade HB;
    Clin Ther; 2013 Nov; 35(11):1805-20. PubMed ID: 24145042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds.
    Cardinal M; Eisenbud DE; Armstrong DG; Zelen C; Driver V; Attinger C; Phillips T; Harding K
    Wound Repair Regen; 2009; 17(3):306-11. PubMed ID: 19660037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
    Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
    Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of diabetic foot].
    Metelko Z; Brkljacić Crkvencić N
    Acta Med Croatica; 2013 Oct; 67 Suppl 1():35-44. PubMed ID: 24371974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matched-cohort study comparing bioactive human split-thickness skin allograft plus standard of care to standard of care alone in the treatment of diabetic ulcers: A retrospective analysis across 470 institutions.
    Barbul A; Gurtner GC; Gordon H; Bakewell K; Carter MJ
    Wound Repair Regen; 2020 Jan; 28(1):81-89. PubMed ID: 31587418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperbaric oxygen therapy for chronic wounds.
    Kranke P; Bennett M; Roeckl-Wiedmann I; Debus S
    Cochrane Database Syst Rev; 2004; (2):CD004123. PubMed ID: 15106239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economics for treatment of diabetic foot ulcers: a cost-effectiveness analysis of eight skin substitutes.
    Samsell B; McLean J; Cazzell S; Dorsch K; Moyer PM; Moore M
    J Wound Care; 2019 Sep; 28(Sup9):S14-S26. PubMed ID: 31509489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.
    Lantis JC; Boone D; Gendics C; Todd G
    Adv Skin Wound Care; 2009 Apr; 22(4):167-71. PubMed ID: 19325276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US.
    Guest JF; Weidlich D; Singh H; La Fontaine J; Garrett A; Abularrage CJ; Waycaster CR
    J Wound Care; 2017 Jan; 26(Sup1):S12-S24. PubMed ID: 28105902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative-pressure wound therapy and diabetic foot amputations: a retrospective study of payer claims data.
    Frykberg RG; Williams DV
    J Am Podiatr Med Assoc; 2007; 97(5):351-9. PubMed ID: 17901338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive Hyperbaric Oxygen Therapy for Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Trial.
    Chen CY; Wu RW; Hsu MC; Hsieh CJ; Chou MC
    J Wound Ostomy Continence Nurs; 2017; 44(6):536-545. PubMed ID: 28968346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of repeated remote ischemic conditioning on diabetic foot ulcers: A proof-of-concept study.
    Regulski M; Greenwood T; Leschinsky B
    Wound Repair Regen; 2021 Sep; 29(5):853-858. PubMed ID: 34236750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.